HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule ...

PIM protein kinases have been known for some time as oncogenes that promote lymphomagenesis together with MYC (c-Myc). It is now reported that PIM1 is a coactivator of MYC, and it phosphorylates ...

Researchers have uncovered a crucial enzyme responsible for a specific chemical modification linked to the growth of a severe ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

UCLA scientists have uncovered a surprising survival strategy in cells, especially cancer cells, that may help explain how ...

Aggressive forms of acute myeloid leukemia (AML) remain challenging to treat, especially in patients with FLT3-ITD mutations.

Kevin Murach, an assistant professor at the University of Arkansas, Fayetteville who previously received a ...

Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making ...

The National Institutes of Health award builds on a previous $2.5 million award to assistant professor Kevin Murach to study to age-associated tissue decline.

AFTER several races had been cancelled due to high winds this year, rowers were keen to take to the water on Sunday, 15 June.